Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.

@article{Rooij2013TowardPS,
  title={Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.},
  author={Kim van Rooij and Saskia Poels and Jos Bloemers and Irwin S. Goldstein and Jeroen Gerritsen and Diana van Ham and Frederiek van Mameren and Meredith L Chivers and W. Th. A. M. Everaerd and H. P. F. Koppeschaar and Berend Olivier and Adriaan Tuiten},
  journal={The journal of sexual medicine},
  year={2013},
  volume={10 3},
  pages={824-37}
}
INTRODUCTION Among other causes, low sexual desire in women may result from dysfunctional activation of sexual inhibition mechanisms during exposure to sex. Administration of sublingual 0.5 mg testosterone (T) increases the sensitivity of the brain to sexual cues, which might amplify sexual inhibitory mechanisms further in women already prone to sexual inhibition. Sexual stimulation might elicit a prefrontal cortex (PFC)-mediated phasic increase in sexual inhibition, in which activity of 5… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…